| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/07/1999 | EP0906243A1 Dissolvable oxides for biological applications |
| 04/07/1999 | EP0906122A2 Activated linkers and methods for making and purifying the same |
| 04/07/1999 | EP0906110A1 Dna vaccine formulations |
| 04/07/1999 | EP0906107A1 Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs |
| 04/07/1999 | EP0906098A1 Virginiamycin mixture |
| 04/07/1999 | EP0906092A1 Pharmaceutical compositions based on diclofenac |
| 04/07/1999 | EP0906089A2 Buccal delivery system |
| 04/07/1999 | EP0906086A1 Composition |
| 04/07/1999 | EP0906069A1 Tissue re-surfacing with hydrogel-cell compositions |
| 04/07/1999 | EP0906015A1 Liver retention clearing agents |
| 04/07/1999 | EP0810855A4 Polyalkylene block copolymers as surface modifiers for nanoparticles |
| 04/07/1999 | EP0764020B1 Transdermal drug delivery system |
| 04/07/1999 | EP0742715B1 Oral liquid compositions containing paroxetine resinate |
| 04/07/1999 | EP0656883B1 Cationic lipids |
| 04/07/1999 | EP0538313B1 Topical ophthalmic suspensions |
| 04/07/1999 | CN1213316A Polymeric delivery of radionuclides and radiopharmaceuticals |
| 04/07/1999 | CN1213301A Sustained-release metal valproate tablets |
| 04/07/1999 | CN1213299A Solid formulations containing trehalose |
| 04/07/1999 | CN1213297A Compositions for treating hair or skin |
| 04/07/1999 | CN1213295A Aqueous product comprising oil microdroplets stabilized by in-situ polymerized binyl monomer and thickening agent |
| 04/07/1999 | CN1213282A Oral peptide pharmaceutical products |
| 04/07/1999 | CN1212890A Compositions useful for transferring therapeutically active substances into target cell, and their use in gene therapy |
| 04/07/1999 | CN1212869A Fixed-dose association of angiotensin-converting enzyme inhibitor and of calcium channel antagonist, method for preparation and use thereof in treatment of cardivas cular illnesses |
| 04/06/1999 | US5892071 Cationic transport reagents |
| 04/06/1999 | US5892043 Camptothecin derivatives |
| 04/06/1999 | US5892026 Supersaturated composition prepared by dissolving syrup at ambient temperature with one or more saccharides as crystal growth inhibitors in equal or greater amount; uncontaminated with bacteria; for foods, feeds, drugs, cosmetics |
| 04/06/1999 | US5892019 Production of a single-gene-encoded immunoglobulin |
| 04/06/1999 | US5891920 Medicinal adjuvants consisting of N-subsitituted-o-toluidine derivatives, and percutaneously absorbable preparations comprising the adjuvants |
| 04/06/1999 | US5891914 Bioactive topical siloxane compositions having enhanced performance and safety |
| 04/06/1999 | US5891911 Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators |
| 04/06/1999 | US5891854 Moisturizers |
| 04/06/1999 | US5891845 Drug delivery systems utilizing liquid crystal structures |
| 04/06/1999 | US5891735 Chemiluminescence |
| 04/06/1999 | US5891704 Method to produce high levels of methioninase |
| 04/06/1999 | US5891689 Heme-bearing microparticles for targeted delivery of drugs |
| 04/06/1999 | US5891478 Composition for sustained release of human growth hormone |
| 04/06/1999 | US5891475 Non-liquid hydrophilic core, an external layer comprised of lipid compounds grafted on the core by covalent bonds. enhancing the activity of the polypeptide cellular mediator. |
| 04/06/1999 | US5891473 Toothpastes |
| 04/06/1999 | US5891472 Topical treatment for administering nitric oxide in lipid based carriers |
| 04/06/1999 | US5891468 Fusogenic liposome compositions and method |
| 04/06/1999 | US5891467 Encapsulation and release of active compounds |
| 04/06/1999 | US5891462 Composition for transdermal administration of an estrogen |
| 04/06/1999 | US5891457 Treating menorrhagia with silver nitrate composition |
| 04/06/1999 | US5891454 Anti-cancer drug and special tumor necrotizing agent |
| 04/06/1999 | CA2248838A1 An intravenous form of thalidomide for the therapy of immunological diseases |
| 04/06/1999 | CA2155005C Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant |
| 04/06/1999 | CA2151774C Skin disinfecting formulations |
| 04/06/1999 | CA2146192C Polyionic insoluble hydrogels comprising xanthan |
| 04/06/1999 | CA2140255C Polyarylates containing derivatives of the natural amino acid l-tyrosine |
| 04/06/1999 | CA2095836C Cytokine immunoconjugates |
| 04/06/1999 | CA2074320C Process for the preparation of microspheres made of a biodegradable polymeric material |
| 04/06/1999 | CA2064190C Process for preparation of an oil in water emulsion of a drug |
| 04/06/1999 | CA2061824C Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
| 04/06/1999 | CA2050045C Pharmaceutical, vaginal applicable preparation and a process for its preparation |
| 04/01/1999 | WO1999015687A1 Multicomponent polynucleotide complex for high efficiency cell transfection |
| 04/01/1999 | WO1999015653A2 Tie ligand homologues |
| 04/01/1999 | WO1999015628A1 Methods and compositions for binding hematopoietic stem cells |
| 04/01/1999 | WO1999015542A2 Linker nucleoside, and production and use of the same |
| 04/01/1999 | WO1999015528A1 Acidic addition salts of morphine alkaloids and the application thereof |
| 04/01/1999 | WO1999015509A2 Cyclohexyl and heterocyclyl nucleoside derivatives, method for producing these derivatives, and the use of the derivatives and their oligomers or conjugates in pairing and/or testing systems |
| 04/01/1999 | WO1999015210A2 Bioadhesive compositions and methods for topical administration of active agents |
| 04/01/1999 | WO1999015201A1 Fucosyl gm1-klh conjugate vaccine against small cell lung cancer |
| 04/01/1999 | WO1999015193A1 LIQUID INTERFERON-β FORMULATIONS |
| 04/01/1999 | WO1999015171A1 Nicotine compositions and methods of formulation thereof |
| 04/01/1999 | WO1999015165A1 Topical non-steroidal anti-inflammatory drug composition |
| 04/01/1999 | WO1999015156A1 Inhibition of crystallization in transdermal devices |
| 04/01/1999 | WO1999015155A1 Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient |
| 04/01/1999 | WO1999015154A1 Methods for fabricating polymer-based controlled release preparations |
| 04/01/1999 | WO1999015150A1 Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| 04/01/1999 | WO1999015147A2 Use of alkylmonoglucosides as molecular vectors |
| 04/01/1999 | WO1999002567A3 Compositions and methods for producing homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells |
| 04/01/1999 | WO1999002545A3 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 04/01/1999 | WO1999002186A3 Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant |
| 04/01/1999 | WO1999002182A3 Non-aqueous vaccines |
| 04/01/1999 | WO1999002120A3 Compositions and methods for reversibly increasing permeability of biomembranes |
| 04/01/1999 | WO1998056370A3 Therapeutic nanospheres |
| 04/01/1999 | WO1998052573A9 Triterpene saponin analogs having adjuvant and immunostimulatory activity |
| 04/01/1999 | WO1998051787A3 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety |
| 04/01/1999 | WO1998039464A8 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 04/01/1999 | WO1998039363A3 Immunotoxins and methods of inducing immune tolerance |
| 04/01/1999 | WO1998024482A3 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them |
| 04/01/1999 | DE19741739A1 Supramolekulares Paarungssystem, dessen Herstellung und Verwendung Supramolecular mating system, its preparation and use |
| 04/01/1999 | CA2304961A1 Methods and compositions for binding hematopoietic stem cells |
| 04/01/1999 | CA2304599A1 Fucosyl gm1-klh conjugate vaccine against small cell lung cancer |
| 04/01/1999 | CA2304191A1 Topical non-steroidal anti-inflammatory drug composition |
| 04/01/1999 | CA2304129A1 Tie ligand homologues |
| 04/01/1999 | CA2304042A1 Nicotine compositions and methods of formulation thereof |
| 04/01/1999 | CA2303527A1 Linker nucleoside, its preparation and use |
| 04/01/1999 | CA2301641A1 Supramolecular pairing system, its preparation and use |
| 03/31/1999 | EP0905254A2 DNA vector associated with biocompatible low molecular weight polyethyleneimines |
| 03/31/1999 | EP0905138A1 Crystals of maltitol of a particular form, crystalline compositions containing them and processes for their preparation |
| 03/31/1999 | EP0904778A1 Stabilized percutaneous absorption preparation |
| 03/31/1999 | EP0904693A1 Pseudoplastic film-forming acidic chlorite composition as teat dip |
| 03/31/1999 | EP0904373A1 Targeted delivery of genes encoding interferon |
| 03/31/1999 | EP0904294A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip) |
| 03/31/1999 | EP0904113A2 Microencapsulated fluorinated gases for use as imaging agents |
| 03/31/1999 | EP0904112A1 Composition comprising interleukin-1 inhibitor and controlled release polymer |
| 03/31/1999 | EP0904111A1 Cosmetic and/or pharmaceutical emulsions containing behenyl derivatives |
| 03/31/1999 | EP0904109A1 Targeting macromolecular prodrugs to t lymphocytes |
| 03/31/1999 | EP0904107A1 Immunoglobin-like domains with increased half lives |